ImmunoGen Revenue, Profits - IMGN Annual Income Statement

Add to My Stocks
$9.04 $0.33 (3.79%) IMGN stock closing price Sep 18, 2018 (Closing)

Looking at financial statements, along with the ImmunoGen stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from - to 115.44M and how operating and non operating activities have impacted the IMGN stock. Revenue for year 2017 is $115.44M and has increased from $- year on year as is evident when you compare the latest figures in the latest ImmunoGen profit and loss statement with those of the prior corresponding period. Also see ImmunoGen assets and ImmunoGen free cash flow for a complete valuation of IMGN stock.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
ImmunoGen Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
ImmunoGen Gross Profit
Research & Development Expense139.73M-38.19M27.64M20.86M21.65M15.55M16M12.21M12.88M
Selling General & Admin Expense34.69M-8.05M6.87M5.44M5.46M4.83M3.68M3.88M3.52M
Income Before Depreciation Depletion Amortization-58.98M--28.22M13.78M3.75M-24.5M-12.77M-15.51M-12.98M-7.07M
Depreciation Depletion Amortization----------
Non Operating Income-20.3M---0.14M---1.28M-0.01M-0.12M
Interest Expense16.72M-5.05M-------
ImmunoGen Pretax Income
Provision for Income Taxes----------0.1M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-96.01M--33.22M13.63M3.81M-24.39M-12.75M-14.23M-13M-7.1M
Extraordinary Items & Discontinued Operations----------
ImmunoGen Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS98.07M86.98M86.04M85.48M84.06M76.81M68.92M58.85M51.07M42.97M
Average Shares used to compute Basic EPS98.07M86.98M86.04M85.48M84.06M76.81M68.92M58.85M51.07M42.97M
Income Before Nonrecurring Items-73.1M-143.66M-60.74M-58.54M-72.81M-73.32M-58.27M-50.91M-31.94M-32.02M
Income from Nonrecurring Items-22.92M---12.82M------
ImmunoGen Earnings Per Share Basic Net
ImmunoGen Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.75-1.65-0.71-0.68-0.87-0.95-0.85-0.87-0.63-0.75
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on ImmunoGen stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $115.44M for this year of 2017. Our ImmunoGen revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like ImmunoGen try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the IMGN income statement, one can check the ImmunoGen historical stock prices to check how the price has moved with time.

ImmunoGen Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield